CA2006529A1 - N-pyridinyl-9h-carbozol-9-amines, procede de preparation et utilisation comme medicaments - Google Patents

N-pyridinyl-9h-carbozol-9-amines, procede de preparation et utilisation comme medicaments

Info

Publication number
CA2006529A1
CA2006529A1 CA2006529A CA2006529A CA2006529A1 CA 2006529 A1 CA2006529 A1 CA 2006529A1 CA 2006529 A CA2006529 A CA 2006529A CA 2006529 A CA2006529 A CA 2006529A CA 2006529 A1 CA2006529 A1 CA 2006529A1
Authority
CA
Canada
Prior art keywords
loweralkyl
hydrogen
medicaments
preparation
halogen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CA2006529A
Other languages
English (en)
Other versions
CA2006529C (fr
Inventor
Richard Charles Effland
Joseph Thomas Klein
Larry Davis
Gordon Edward Olsen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2006529A1 publication Critical patent/CA2006529A1/fr
Application granted granted Critical
Publication of CA2006529C publication Critical patent/CA2006529C/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Hospice & Palliative Care (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Indole Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Hydrogenated Pyridines (AREA)
CA002006529A 1988-12-27 1989-12-22 N-pyridinyl-9h-carbozol-9-amines, procede de preparation et utilisation comme medicaments Expired - Fee Related CA2006529C (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/289,887 US4868190A (en) 1988-12-27 1988-12-27 N-pyridinyl-9H-carbazol-9-amines
US289,887 1988-12-27

Publications (2)

Publication Number Publication Date
CA2006529A1 true CA2006529A1 (fr) 1990-06-27
CA2006529C CA2006529C (fr) 1999-08-10

Family

ID=23113557

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002006529A Expired - Fee Related CA2006529C (fr) 1988-12-27 1989-12-22 N-pyridinyl-9h-carbozol-9-amines, procede de preparation et utilisation comme medicaments

Country Status (19)

Country Link
US (1) US4868190A (fr)
EP (1) EP0376155B1 (fr)
JP (1) JPH0725749B2 (fr)
KR (1) KR900009596A (fr)
AT (1) ATE79118T1 (fr)
AU (1) AU623205B2 (fr)
CA (1) CA2006529C (fr)
DE (1) DE68902386T2 (fr)
DK (1) DK662189A (fr)
ES (1) ES2044043T3 (fr)
FI (1) FI896243A7 (fr)
GR (1) GR3006140T3 (fr)
IE (1) IE894175L (fr)
IL (1) IL92867A0 (fr)
NO (1) NO895222L (fr)
NZ (1) NZ231943A (fr)
PH (1) PH27122A (fr)
PT (1) PT92696A (fr)
ZA (1) ZA899904B (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4916135A (en) * 1989-05-08 1990-04-10 Hoechst Roussel Pharmaceuticals Inc. N-heteroaryl-4-quinolinamines
DK0415103T3 (da) * 1989-08-02 1995-06-19 Hoechst Roussel Pharma 2,3-Dihydro-1-(pyridinylamino)-indoler, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
US5179099A (en) * 1989-08-02 1993-01-12 Hoechst-Roussel Pharmaceuticals Incorporated 2,3-dihydro-1-(pyridinylamino)-indoles
US4994472A (en) * 1989-08-02 1991-02-19 Hoechst-Roussel Pharmaceuticals Incorporated 1-(pyridinylamino)-2-pyrrolidinones as pain relievers
US4983608A (en) * 1989-09-05 1991-01-08 Hoechst-Roussell Pharmaceuticals, Inc. N-substituted-4-pyrimidinamines and pyrimidinediamines
NZ312577A (en) * 1995-07-27 1999-08-30 Hoechst Marion Roussel Inc Use of optionally substituted n-(pyrrol-1-yl)-pyridinamines as anticonvulsant agents
US5776955A (en) * 1995-07-27 1998-07-07 Hoechst Marion Roussel, Inc. Use of unsubstituted and substituted n-(pyrrol-1-yl)pyridinamines as anticonvulsant agents
ZA989365B (en) * 1997-10-15 1999-04-15 Boehringer Mannheim Pharm Corp Preparation for treating alzheimer's disease
ATE267629T1 (de) * 2000-07-21 2004-06-15 Ortho Mcneil Pharm Inc Verwendung von carbamat verbindungen zur vorbeugung oder behandlung von neuropathischen- , cluster- und migräneartigen kopfschmerzen

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH475982A (de) * 1966-11-16 1969-07-31 Wander Ag Dr A Verfahren zur Herstellung von Carbazolderivaten
EP0073849A1 (fr) * 1981-09-03 1983-03-16 Schering Corporation Phényltétrahydro-1,2,3,4 carbazoles, leur préparation et compositions pharmaceutiques les contenant
US4752610A (en) * 1985-12-04 1988-06-21 Hoechst-Roussel Pharmaceuticals Inc. N-(pyrrol-1-yl)pyridinamines having memory enhancing properties
US4792562A (en) * 1985-12-04 1988-12-20 Hoechst-Roussel Pharmaceuticals, Inc. N-(pyrrol-1-yl)pyridinamines having memory enhancing activity
ATE115143T1 (de) * 1987-04-24 1994-12-15 Hoechst Roussel Pharma N-(pyridinyl)-1h-indol-1-amine, verfahren zu deren herstellung und ihre verwendung als arzneimittel.
US4806554A (en) * 1988-01-11 1989-02-21 Hoechst-Roussel Pharmaceuticals, Inc. Pyrazol and indazolpyridinamines
US4916135A (en) * 1989-05-08 1990-04-10 Hoechst Roussel Pharmaceuticals Inc. N-heteroaryl-4-quinolinamines
DK0415103T3 (da) * 1989-08-02 1995-06-19 Hoechst Roussel Pharma 2,3-Dihydro-1-(pyridinylamino)-indoler, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
US5006537A (en) * 1989-08-02 1991-04-09 Hoechst-Roussel Pharmaceuticals, Inc. 1,3-dihydro-1-(pyridinylamino)-2H-indol-2-ones

Also Published As

Publication number Publication date
NZ231943A (en) 1992-06-25
JPH0725749B2 (ja) 1995-03-22
FI896243A7 (fi) 1990-06-28
EP0376155A1 (fr) 1990-07-04
PT92696A (pt) 1990-06-29
US4868190A (en) 1989-09-19
DK662189D0 (da) 1989-12-22
GR3006140T3 (fr) 1993-06-21
NO895222L (no) 1990-06-28
PH27122A (en) 1993-03-16
DK662189A (da) 1990-06-28
NO895222D0 (no) 1989-12-22
AU4720389A (en) 1990-07-05
IE894175L (en) 1990-06-27
KR900009596A (ko) 1990-07-05
ATE79118T1 (de) 1992-08-15
FI896243A0 (fi) 1989-12-22
CA2006529C (fr) 1999-08-10
JPH02247173A (ja) 1990-10-02
ZA899904B (en) 1991-02-27
IL92867A0 (en) 1990-09-17
DE68902386T2 (de) 1993-02-11
ES2044043T3 (es) 1994-01-01
AU623205B2 (en) 1992-05-07
DE68902386D1 (de) 1992-09-10
EP0376155B1 (fr) 1992-08-05

Similar Documents

Publication Publication Date Title
CA2024572A1 (fr) 4-pyrimidinamines et pyrimidinediamines substituees en n, procede depreparation et utilisation comme medicaments
CA2019957A1 (fr) Heteroarylamino- et heteroaryloxypyridinamines et composes apparentes, procede de preparation et utilisation en dermatologie
AU589029B2 (en) Alpha-alkyl-4-amino-3-quinolinemethanols and 1-(4-aralkylamino-3-quinolinyl) alkanones, a process for their preparation and their use as medicaments
CA2006529A1 (fr) N-pyridinyl-9h-carbozol-9-amines, procede de preparation et utilisation comme medicaments
PL313078A1 (en) Novel bis-naphtalimides for use in treating carcinoma
CA2028287A1 (fr) Benzocycloalkylaminopyridinamines et composes connexes, procede et intermediaires pour leur preparation et leur utilisation comme medicaments
HU895830D0 (en) Process for the preparation of 1,2,3,4-tetrahydro-1,9-acridine-diamines and pharmaceutical compositions containing said compounds
AU625221B2 (en) (1,2,3,4-tetrahydro-9-acridinimino)cyclohexae carboxylic acid and related compounds, a process for their preparation and their use as medicaments
CA2003023A1 (fr) Hydroxy-1,2,3,4-tetrahydroaminoacridines, procede de preparation et utilisation comme medicaments
AU619985B2 (en) 4,5,5a,6-tetrahydro-3h-isoxazolo(5,4,3-kl)acridines derivatives, a process for their preparation and their use as medicaments

Legal Events

Date Code Title Description
EEER Examination request
MKLA Lapsed